据一份报纸周五透露，印度的Maxivision Super Specialty Eye Hospitals（由专注于医疗健康的收购公司Quadria Capital支持）已秘密申请首次公开募股（IPO）。
India’s Maxivision Super Specialty Eye Hospitals, backed by healthcare-focused buyout firm Quadria Capital, has confidentially filed for an initial public offering, a newspaper showed on Friday.
路透社7月曾报道，这家眼科连锁机构已委任ICICI Securities和IIFL Capital作为IPO的承销商，该IPO将包含新发行股份和现有投资者出售股份的组合。
Reuters had reported in July that the eye-care chain had appointed ICICI Securities and IIFL Capital as bankers for an IPO that would include a mix of newly issued shares and stock sold by existing investors.
印度的保密申报机制允许公司向市场监管机构提交IPO草案文件而不公开披露，在寻求监管批准的同时保持财务和运营细节的私密性。
India’s confidential filing mechanism allows companies to submit draft IPO papers to the market regulator without public disclosure, keeping financial and operational details private while seeking regulatory approval.
Maxivision成立于1996年，在六个州经营超过90家中心，与Dr. Agarwal’s Health Care、Centre for Sight和ASG Eye Hospitals等连锁机构竞争。
Founded in 1996, Maxivision operates more than 90 centres across six states, and competes with chains including Dr. Agarwal’s Health Care, Centre for Sight and ASG Eye Hospitals.
根据Grand View Research的数据，印度眼科护理市场预计将从2025年的128亿美元增长到2033年的312亿美元。
India’s eye-care market is projected to grow to $31.2 billion by 2033 from $12.8 billion in 2025, according to Grand View Research.